# United Kingdom User Evaluation, MiniMed Paradigm® X54 System

> **NCT01267175** · PHASE4 · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** X54 insulin pump with low suspend feature

## Key facts

- **NCT ID:** NCT01267175
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267175, "United Kingdom User Evaluation, MiniMed Paradigm® X54 System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01267175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*